Good clinical practice points on the use of acetylcholinesterase inhibitors in myasthenia gravis: Recommendations from the Special Interest Group in Myasthenia Gravis in Asia

BS Wibowo; HC Chiu; HLF Damian; J Misbach; KH Chan; KJ Goh; KY Goh; N Shahrizaila; R Witoonpanich; RL Rosales; S Chankrachang; SD Puvanarajah; T Umapathi; YL Lo

首页> 外文期刊>Neurological Journal of South East Asia >Good clinical practice points on the use of acetylcholinesterase inhibitors in myasthenia gravis: Recommendations from the Special Interest Group in Myasthenia Gravis in Asia

【24h】

Good clinical practice points on the use of acetylcholinesterase inhibitors in myasthenia gravis: Recommendations from the Special Interest Group in Myasthenia Gravis in Asia

机译：在重症肌无力中使用乙酰胆碱酯酶抑制剂的良好临床实践要点：亚洲重症肌无力特别兴趣小组的建议

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Neurological Journal of South East Asia》 |2009年第2009期|共页
作者
BS Wibowo; HC Chiu; HLF Damian; J Misbach; KH Chan; KJ Goh; KY Goh; N Shahrizaila; R Witoonpanich; RL Rosales; S Chankrachang; SD Puvanarajah; T Umapathi; YL Lo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类神经科学;
关键词

相似文献

外文文献
中文文献
专利

1. Good clinical practice points on the use of acetylcholinesterase inhibitors in myasthenia gravis: Recommendations from the Special Interest Group in Myasthenia Gravis in Asia [J] . BS Wibowo, HC Chiu, HLF Damian, Neurology Asia . 2009,第2009期

机译：在重症肌无力中使用乙酰胆碱酯酶抑制剂的良好临床实践要点：亚洲重症肌无力特别兴趣小组的建议
2. Clinical Significance of Repetitive Compound Muscle Action Potentials in Patients with Myasthenia Gravis: A Predictor for Cholinergic Side Effects of Acetylcholinesterase Inhibitors [J] . Lee Hyo Eun, Kim Yool-hee, Kim Seung Min, Journal of Clinical Neurology . 2016,第4期

机译：重症肌无力患者重复性复合肌肉动作电位的临床意义：乙酰胆碱酯酶抑制剂的胆碱能副作用的预测因子。
3. Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular Hyperactivity [J] . Shin Ha Young, Park Hyung Jun, Lee Hyo Eun, Journal of Clinical Neurology . 2014,第2期

机译：MuSK抗体阳性重症肌无力对乙酰胆碱酯酶抑制剂的临床和电生理反应：胆碱能神经肌肉活动亢进的证据。
4. Factors contributing to failure of neuromuscular transmission in myasthenia gravis and the special case of the extraocular muscles [C] . Alessandro Serra, Robert Ruff, Henry Kaminski, Basic and Clinical Ocular Motor and Vestibular Research: A Tribute to R. John Leigh . 2011

机译：导致神经肌肉传播失败的因素，肌炎肌肉肌瘤和视网膜特殊情况
5. CLINICAL, GENETIC AND MORPHOLOGICAL CHARACTERIZATION OF CONGENITAL MYASTHENIA GRAVIS IN THE SMOOTH FOX TERRIER (PATHOLOGY). [D] . MILLER, LISA MAAG. 1984

机译：先天性重症肌无力狗的临床，遗传和形态学特征（病理）。
6. A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group. [O] . 1993

机译：比较泼尼松和硫唑嘌呤在重症肌无力中的随机临床试验。第二次中期分析的结果。重症肌无力临床研究组。
7. A randomised clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. Myasthenia Gravis Clinical Study Group. [O] . 1993

机译：比较泼尼松和硫唑嘌呤在重症肌无力中的随机临床试验。第二次中期分析的结果。重症肌无力临床研究组。

Good clinical practice points on the use of acetylcholinesterase inhibitors in myasthenia gravis: Recommendations from the Special Interest Group in Myasthenia Gravis in Asia

著录项

引文网络

相似文献

相关主题

期刊订阅